Tech Company Financing Transactions
Lindus Health Funding Round
On 1/22/2025, Lindus Health raised $55 million in Series B investment from Balderton Capital, Creandum and Firstminute Capital.
Transaction Overview
Company Name
Announced On
1/22/2025
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to further develop its proprietary AI technology and eClinical platform, Citrus�, to optimize study design, automate central monitoring of study data, enable instant biostatistics, and more.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Taper Studios, The Leather Market Weston Street Unit A, Berm
London, England, SE1 3ER
UK
London, England, SE1 3ER
UK
Phone
Undisclosed
Website
Email Address
Overview
Operator of a tech-driven anti-contract research organization intended to deliver end-to-end clinical trials for health and biotech companies. The company's software platform accesses electronic health records, and designs and executes entire clinical trials end-to-end for life science companies, creating huge value for our customers by reducing their time to market and the risk of clinical trial failure, enabling health experts to capture more of the value chain, at higher margins, creating a sustainable competitive advantage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Technical Officer
Nik Haldimann
Co-Founder
Michael Young
Browse more venture capital transactions:
Prev: 1/22/2025: Neko Health venture capital transaction
Next: 1/22/2025: Addis Energy venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs